Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome: Randomized Controlled Trial
Latest Information Update: 06 Aug 2025
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
Most Recent Events
- 22 Jul 2025 Planned End Date changed from 1 Apr 2025 to 25 Aug 2025.
- 22 Jul 2025 Planned primary completion date changed from 30 Mar 2025 to 30 Jul 2025.
- 22 Jan 2025 New trial record